Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.

ASHKELON, Israel -- Integrity Applications, Inc., developer of the GlucoTrack model DF-F noninvasive blood glucose measurement device, announced today that it has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into a Manufacturing Agreement with Wistron Corp, the manufacturing arm of Acer Inc. Pursuant to the agreement, Wistron has agreed to manufacture and service (on a non-exclusive basis) the GlucoTrack Model DF-F and any future products, if any, introduced by the Company. Wistron has agreed to provide full turn-key manufacturing services for the GlucoTrack model DF-F, including components procurement, units assembly, device integration, testing and packaging.

About GlucoTrack

GlucoTrack features a small sensor that clips to the earlobe and measures the wearer's blood glucose level by taking measurements using three technologies. The measurements are analyzed using a proprietary algorithm and displayed on a small handheld device, the size of a mobile phone. The derived blood glucose measurement is also announced verbally, making it suitable for the elderly and vision-impaired diabetes patients. The Company has obtained a CE Mark approval for its GlucoTrack Model DF-F in Europe (June 2013) and intends to seek Food and Drug Administration approval for GlucoTrack Model DF-F in the United States.

For more information, visit http://www.integrity-app.com
 

Suggested Articles

Accessible point-of-care devices could transform both agriculture and medicine.

Global magnetic sensor market is anticipated to reach $3,053.5 Million by 2028.

A unique power- and data-efficient system architecture for the always-on era.